Behavioral Therapy and Hypnotherapy Both Reduced Drinking in Alcohol Use Disorder
Alcohol use disorder remains a relapsing condition in which craving, compulsive use, and impaired control often reinforce one another long after treatment begins. In a randomized controlled trial published in Scientific Reports, two structured psychotherapies — Combined Behavioral Intervention and Ericksonian Hypnotherapy — each outperformed a psychoeducational control condition across the trial’s main alcohol-use outcomes. The study adds a rare direct comparison between a standard behavioral package and a more individualized, experiential approach in adults meeting DSM-5 criteria for AUD.
Ninety adults were randomized 1:1:1, and both active interventions were delivered individually over 12 weekly sessions. The primary outcomes were built around three Timeline Follow-Back indices covering the previous 30 days: drinking days, heavy drinking days, and drinks per drinking day. That structure matters because the endpoints capture not just whether participants drank, but how often and how intensely they drank, two dimensions that define clinical risk in alcohol use disorder.
The findings were directionally consistent across the primary family of outcomes. Both active treatments produced significantly greater improvement than control, with moderate-to-large between-group effects across alcohol-use measures. In practical terms, the trial did not hinge on a narrow signal buried in one metric; it showed convergence across multiple ways of counting alcohol exposure.
A Three-Arm Design Separated Alcohol Outcomes From Symptom Relief
The trial was designed to test more than drinking behavior alone. Craving, depressive symptoms, anxiety symptoms, quality of life, and readiness for change were also measured as secondary and exploratory outcomes, providing a wider view of how psychotherapy can reshape the clinical burden of AUD. The primary analysis used an intention-to-treat linear mixed-effects model including all randomized participants, with completer and multiple-imputation analyses used as sensitivity checks. Multiplicity was controlled across the confirmatory family of primary outcomes, which strengthens confidence in the alcohol-use comparisons themselves.
The two active treatments did not differ significantly from each other on alcohol-use outcomes. In a therapeutic field where non-significant differences are often misread as proof of sameness, the trial is more careful than that. The absence of a statistically significant separation between Combined Behavioral Intervention and Ericksonian Hypnotherapy does not establish equivalence; it simply means this study was not powered to settle that question.
A different pattern emerged in the exploratory domains. Contrasts between the active treatments favored Ericksonian hypnotherapy on craving-related cognitions, obsessive craving, and anxiety severity. Those comparisons were preliminary, not powered a priori, and should be treated as hypothesis-generating rather than definitive. Still, the direction of the signal is clinically interesting because craving and anxiety often intensify each other in AUD, creating a feedback loop that can undermine abstinence or controlled drinking efforts.
Why an Experiential Approach May Matter for Craving and Anxiety
Ericksonian hypnotherapy is not part of the usual first-line conversation in many addiction clinics, yet the mechanism it targets is easy to understand from a bedside perspective. If a therapy can alter how a patient experiences craving, anticipatory anxiety, and automatic drinking cues, it may interrupt the internal sequence that turns stress into drinking behavior. The trial’s exploratory results fit that logic. By comparison, combined behavioral intervention is a more established structured psychotherapy package, and its strong performance across the alcohol-use endpoints reinforces the value of a direct, skills-based treatment model.
The separation between drinking outcomes and symptom outcomes is clinically meaningful. A patient may cut down on drinking before subjective distress fully settles, or feel less anxious while still needing continued work on alcohol consumption itself. This trial captured both dimensions without collapsing them into a single endpoint, which gives the results more credibility as a treatment story rather than a simple before-and-after measure.
Because all participants were treated individually over 12 weekly sessions, the data also speak to a fairly intensive outpatient psychotherapy model rather than a brief educational contact. That dosage likely matters. Chronic alcohol use is rarely sustained by a single driver; it is maintained by cues, habit learning, emotional reactivity, and distorted expectations about relief. Psychotherapy that engages those layers consistently over time has a better chance of changing behavior than one-off advice.
Control Condition, Fidelity Oversight, and What the Trial Can and Cannot Claim
The control condition was psychoeducation, which provides an important reference point because it reflects information delivery without the active therapeutic machinery of either intervention. Against that baseline, both active arms were clearly superior on the trial’s main drinking outcomes. The study also included independent treatment adherence and fidelity monitoring, led by Professor Mansur Beyazyürek, which is an important safeguard when comparing two psychologically intensive interventions that depend on delivery quality as much as theory.
The trial’s authors also reported no specific grant support from public, commercial, or not-for-profit agencies. Ethics approval came from the İstanbul Nişantışı University Social and Human Sciences Ethics Committee, and written informed consent was obtained from all participants before enrollment. Those details do not change the clinical signal, but they do clarify the procedural integrity of the study.
The data do not support reading too much into the head-to-head comparison between the two active treatments. With 90 participants total, the trial is well suited to detecting broad differences from control, but not to definitively resolving finer distinctions between two active psychotherapies. The strongest conclusion is the simplest one: structured psychotherapy helped, and both treatment packages beat psychoeducation on alcohol-use outcomes.
What This Means for AUD Treatment Selection
For clinicians treating alcohol use disorder, the study reinforces a familiar principle with fresh comparative data: a structured psychological intervention can still move core drinking outcomes even in a disorder marked by relapse and ambivalence. It also introduces Ericksonian hypnotherapy as a candidate treatment package worth formal testing in a larger, adequately powered trial. The preliminary signals on craving and anxiety are especially relevant because those symptoms often drive recurrence after initial improvement.
The trial leaves an important question open. Which patients, with which symptom profiles, are most likely to benefit from a skills-based behavioral package versus a more experiential, suggestion-oriented approach? The current data do not answer that, and the sample size cannot reliably sort out moderators of response. A future study with larger numbers, longer follow-up, and direct relapse endpoints would be needed to determine whether the early advantages seen for craving and anxiety translate into more durable drinking reduction.
For now, the evidence supports a narrower but clinically useful conclusion: in adults with alcohol use disorder, both Combined Behavioral Intervention and Ericksonian Hypnotherapy improved drinking outcomes over psychoeducational control, while the more experimental therapy showed preliminary advantages on craving-related and anxiety measures that merit further study.